小脑线粒体DNA复制数在帕金森病中增加
Talia Beglarian1, David R Tyrpak1,2, J Raphael Gibbs3
1Department of Translational Genomics, Keck School of Medicine, University of Southern California, 1450 Biggy St. NRT 2502, Los Angeles, CA 90033, USA.
Brain communications
|August 28, 2025
概括
帕金森病 (PD) 的大脑在小脑中显示出更高的线粒体DNA复制数. 这种增加与疾病的严重程度相关,并表明病理或运动症状的补偿反应.
科学领域:
- 神经科学
- 遗传学
- 生物信息学
背景情况:
- 线粒体功能障碍与帕金森病有关.
- 量化线粒体DNA (mtDNA) 拷贝数对于理解神经系统疾病中的细胞能量是至关重要的.
- 全基因组测序 (WGS) 提供了一种评估mtDNA拷贝数的方法.
研究的目的:
- 用生物信息学工具评估来自帕金森病患者和对照组的人类大脑样本中的线粒体DNA复制数.
- 研究mtDNA拷贝数与PD神经病理和临床评分之间的相关性.
主要方法:
- 使用快速MitoCalc工具对341个帕金森病 (PD) 小脑样本和74个年龄匹配对照的全基因组测序 (WGS) 数据进行了分析.
- 在五个大脑库中评估可复制性.
- 相关的mtDNA拷贝数与Lewy体疾病统一分级系统和统一帕金森病评分表 (UPDRS) 的得分.
- 分析了10个大脑区域的Lewy体得分.
主要成果:
- 与对照组相比,在帕金森病小脑中观察到显著更高的线粒体DNA复制量 (P = 4. 15e-7).
- 这一发现可以在五个脑库中的四个中复制.
- 增加的mtDNA复制数与较高的勒维体分期和UPDRS运动分数相关.
- 小脑mtDNA复制数在脑干和边缘系统的α-synuclein聚合时增加,但在晚期新皮层参与时没有增加.
结论:
- 小脑线粒体DNA复制数在帕金森病中升高.
- 这种升高可能是对 PD 病理和运动症状增加的代谢需求或区域激活的补偿机制.
- 这些发现支持小脑参与PD的发病.
相关概念视频
Animal Mitochondrial Genetics
8.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.0K
Mitochondria
14.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.9K
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376


